TIMP1 and cancer: In particular, Zhang et al. found that the presurgery peripheral blood levels of TIMP-1 and MMP9 in patients with differentiated TCs are significantly elevated, although TIMP-1 expression levels still remain lower than MMP-9 levels, thus promoting the development of cancer because the balance between the two was broken (141).